Open Access

Hyperbaric oxygen therapy ameliorates pain in overweight or obese patients diagnosed with fibromyalgia

  • Authors:
    • Juan-Guillermo Winfield‑Vargas
    • Julio C. Ramírez‑Nava
    • Valentín Rodríguez‑Ayala
    • Juan A. Cruz‑Sánchez
    • Héctor Solís‑Chagoyán
    • Arnoldo Aquino‑Gálvez
    • Bianca S. Romero‑Martínez
    • Luis M. Montaño
    • Edgar Flores‑Soto
  • View Affiliations

  • Published online on: May 12, 2021     https://doi.org/10.3892/wasj.2021.107
  • Article Number: 36
  • Copyright: © Winfield‑Vargas et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Fibromyalgia is a syndrome characterized by widespread musculoskeletal pain, fatigue, poor sleep quality, allodynia and paresthesia. Therapy for this syndrome consists of pharmacological and non‑pharmacological approaches focused on controlling pain and fatigue to improve the quality of life of those affected. The present study aimed to determine whether hyperbaric oxygen therapy (HBOT) can be considered a useful adjuvant of pre‑existing pharmacological treatment to reduce pain and improve the quality of life of patients with fibromyalgia. Patients diagnosed with fibromyalgia were enrolled in the present study following a clinical evaluation. All participants received 20 sessions of HBOT (five sessions/week, Monday‑Friday). The sessions consisted of breathing for 60 min with 100% oxygen at a 2.0 atmospheric absolute pressure. Pain, fatigue, quality of life and the number of drugs used were measured to assess the effectiveness of HBOT. Prior to HBOT, the patients presented with an average visual analog scale score of 8.06±0.475, which was reduced to 3.86±0.748 following treatment. In addition, the functional assessment of chronic illness therapy‑fatigue score indicated amelioration of this symptom by HBOT, reducing the mean score from 44.86±2.19 to 21.6±1.09. Furthermore, the quantification of the quality of life using the fibromyalgia impact questionnaire reduced the score from 76.66±4.11 to 47.6±2.67. As regards the number of drugs administered to the patients, this decreased from 3.13±0.764 to 1.53±0.85. Taken together, the results of the present study suggest that HBOT may be used as an effective adjuvant in the treatment of fibromyalgia, reducing both pain and fatigue. In addition, this treatment improves the quality of life of those affected and may be used to avoid polypharmacy.
View Figures
View References

Related Articles

Journal Cover

July-August 2021
Volume 3 Issue 4

Print ISSN: 2632-2900
Online ISSN:2632-2919

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Winfield‑Vargas J, Ramírez‑Nava JC, Rodríguez‑Ayala V, Cruz‑Sánchez JA, Solís‑Chagoyán H, Aquino‑Gálvez A, Romero‑Martínez BS, Montaño LM and Flores‑Soto E: Hyperbaric oxygen therapy ameliorates pain in overweight or obese patients diagnosed with fibromyalgia. World Acad Sci J 3: 36, 2021
APA
Winfield‑Vargas, J., Ramírez‑Nava, J.C., Rodríguez‑Ayala, V., Cruz‑Sánchez, J.A., Solís‑Chagoyán, H., Aquino‑Gálvez, A. ... Flores‑Soto, E. (2021). Hyperbaric oxygen therapy ameliorates pain in overweight or obese patients diagnosed with fibromyalgia. World Academy of Sciences Journal, 3, 36. https://doi.org/10.3892/wasj.2021.107
MLA
Winfield‑Vargas, J., Ramírez‑Nava, J. C., Rodríguez‑Ayala, V., Cruz‑Sánchez, J. A., Solís‑Chagoyán, H., Aquino‑Gálvez, A., Romero‑Martínez, B. S., Montaño, L. M., Flores‑Soto, E."Hyperbaric oxygen therapy ameliorates pain in overweight or obese patients diagnosed with fibromyalgia". World Academy of Sciences Journal 3.4 (2021): 36.
Chicago
Winfield‑Vargas, J., Ramírez‑Nava, J. C., Rodríguez‑Ayala, V., Cruz‑Sánchez, J. A., Solís‑Chagoyán, H., Aquino‑Gálvez, A., Romero‑Martínez, B. S., Montaño, L. M., Flores‑Soto, E."Hyperbaric oxygen therapy ameliorates pain in overweight or obese patients diagnosed with fibromyalgia". World Academy of Sciences Journal 3, no. 4 (2021): 36. https://doi.org/10.3892/wasj.2021.107